SecBot SecBot
PRESS-RELEASE ·Filed Mar 26, 2026

POCI

Precision Optics Corporation
NEUTRAL
Impact 4/10
Horizondays Processed7mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight • Neutral

Traders should monitor for the filing of the preliminary prospectus supplement to assess offering size, pricing, and use of proceeds, which will clarify the dilutive impact and strategic intent.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
POCI ▲ +22.67% at T+60d
NEUTRAL call +22.67% · α vs SPY +6.61% · entry $4.19 → $5.14
Entry = T+0 close
Mar 26, 2026
via day close
T+1d
+0.24%
call +0.24% · α +0.60%
$4.20
settled 7mo ago
T+5d
-4.53%
call -4.53% · α -8.40%
$4.00
settled 7mo ago
T+20d
0.00%
call 0.00% · α -12.74%
$4.19
settled 6mo ago
T+60d
+22.67%
call +22.67% · α +6.61%
$5.14
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Precision Optics Corporation (POCI) announced it is commencing an underwritten public offering of its common stock, subject to market conditions and regulatory filings. The offering will be made via a shelf registration statement, with Lucid Capital Markets as sole book-runner, though specific terms such as size, pricing, and use of proceeds were not disclosed.

Key Facts

  • Precision Optics Corporation (POCI) is initiating an underwritten public offering of common stock or common stock equivalents.
  • The offering is subject to market conditions; no assurance it will be completed.
  • Lucid Capital Markets is acting as sole book-running manager.
  • Offering is made under a shelf registration (Form S-3) filed June 2024 and declared effective June 14, 2024.
  • Preliminary prospectus supplement will be filed with the SEC; no financial terms disclosed in this release.

Financial Impact

Potential dilution and capital raise dependent on final offering size and pricing, which are not disclosed.

dilutionequitycash

Risk Factors

  • Potential share dilution upon completion of the offering.
  • Market reaction may be negative if offering is priced at a significant discount to current market value.
  • Uncertainty around timing and final terms increases volatility risk ahead of definitive disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3263387
9 reports for POCI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for POCI — sortable, filterable
TypeNow
Oct 27, 2026
today
DEFA14A
NEUTRAL ★ 2/10
$4.34awaiting T+60—$4.41 (+1.61%)
Oct 27, 2026
today
DEF 14A
NEUTRAL ★ 4/10
$4.34awaiting T+60—$4.41 (+1.61%)
Sep 28, 2026
29d ago
Press Release
MIXED ★ 5/10
$4.27awaiting T+60—$4.41 (+3.28%)
Sep 23, 2026
4w ago
Press Release
NEUTRAL ★ 1/10
$4.78awaiting T+60—$4.41 (−7.64%)
May 13, 2026
23w ago
Press Release
BULLISH ★ 7/10
$4.78 $4.24▼ −11.30%▼ −14.89%$4.41 (−7.74%)
Mar 30, 2026
30w ago
Insider Cluster
BULLISH ★ 7/10
$4.20 $5.09▲ +21.19%▲ +4.70%$4.41 (+5.00%)
Mar 27, 2026
30w ago
Press Release
NEUTRAL ★ 5/10
$4.19 $5.14▲ +22.67%▲ +6.61%$4.41 (+5.25%)
Mar 26, 2026
30w ago
424B5
NEUTRAL ★ 4/10
$4.19 $5.14▲ +22.67%▲ +6.61%$4.41 (+5.25%)
Mar 26, 2026
30w ago
Press Release
NEUTRAL ★ 4/10
$4.19 $5.14▲ +22.67%▲ +6.61%$4.41 (+5.25%)
Showing 9 of 9

US Market Status

Market Closed — Opens Wed (16h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 26, 2026